The cardiac sarcoplasmic reticulum calcium release channel, commonly referred to as the ryanodine receptor, is a key component in cardiac excitation-contraction coupling, where it is responsible for the release of calcium from the sarcoplasmic reticulum. As our knowledge of the ryanodine receptor has advanced an appreciation that this key E-C coupling component may have a role in the pathogenesis of human cardiac disease has emerged. Heart failure and arrhythmia generation are both pathophysiological states that can result from deranged excitation-contraction coupling. Evidence is now emerging that hyperphosphorylation of the cardiac ryanodine receptor is an important event in chronic heart failure, contributing to impaired contraction and the generation of triggered ventricular arrhythmias. Furthermore the therapeutic benefits of b blockers in heart failure appear to be partly explained through a reversal of this phenomenon. Two rare inherited arrhythmogenic conditions, which can cause sudden death in children, have also been shown to result from mutations in the cardiac ryanodine receptor. These conditions, catecholaminergic polymorphic ventricular tachycardia and arrhythmogenic right ventricular cardiomyopathy (subtype 2), further implicate the ryanodine receptor as a potentially arrhythmogenic substrate and suggest that this channel may offer a new therapeutic target in the treatment of both cardiac arrhythmias and heart failure. 
. The cardiac ryanodine receptor and excitation-con-
of heart failure and cardiac arrhythmias, as Ca is traction coupling required to maintain the inotropic and electrical properties of the heart. In this article we will review recent work that 21 It is widely accepted that Ca plays a key role in the has provided an insight into how altered RyR function may heart with regards to excitation-contraction (E-C) coucontribute to the pathogenesis of heart failure and cardiac 21 pling and crucial to this is the Ca release channel, arrhythmias. commonly referred to as the ryanodine receptor (RyR) [1] [2] [3] . RyR is a large conductance cation-selective ion 1 .1. RyR: structure and nomenclature channel found within the sarcoplasmic reticulum (SR) 21 Three mammalian isoforms of RyR have been identified membrane where it is responsible for the release of Ca and cloned [2] . Isoform 1 (RyR1) is found within skeletal from this intracellular storage organelle [2] . Although muscle, isoform 2 (RyR2) is the predominant form in much is known about its structure and functional propcardiac muscle and isoform 3 (RyR3) is expressed at low erties, only recently has attention turned to its potential levels in various tissues. The channel is a high molecular role in cardiac disease. It is not surprising that an ion weight homotetramer that traverses the SR membrane. Its channel with a key role in the intracellular pathways of 21 then be utilised in various Ca signalling processes such buffered by calsequestrin. This so-called 'calcium induced 21 calcium release' [7] raises cytosolic Ca to the level as muscle contraction. Each monomer contains approxi- 21 required for contraction. Ca is released in a synchronised mately 5000 amino acids and has a molecular weight of manner from individual RyR2 populations and this phe-565 kDa [5] . The majority of RyR2 channels in carnomenon is directly visible using confocal microscopy and diomyocytes are distributed in areas of the SR membrane 21 has been termed a Ca spark [8] . Depolarisation leads to that lie in proximity to the T-tubule invaginations of the a co-ordinated release from multiple spark sites, producing sarcolemmal membrane [6] . Here they are closely associ- 21 21 21 a global Ca transient that allows sufficient Ca to bind ated with the L-type voltage-dependent Ca channel and with troponin C, initiating contraction. this spatial association of the two channels is key to the 21 For relaxation to occur Ca must dissociate from signal amplification process that underlies cardiac E-C 21 troponin C and this requires a reduction in cytosolic Ca . coupling (Fig. 1) . 1 
21
The sarcolemmal Na / Ca exchanger transports Ca 21 out of the cell and the SR Ca /ATPase pump actively 1 .2. Cardiac excitation-contraction coupling 21 21 replenishes SR Ca stores [9] . Furthermore SR Ca release must be stopped and RyR2 closed. The mechaCardiac E-C coupling is the process where by excitation nisms that bring about this are still debated and a combinaof the cardiomyocyte, in the form of membrane depolarisa- 21 tion of factors including stochastic attrition, RyR2 adaptation, is used as a stimulus for the movement of Ca may all contribute, possibly in a synergistic manner [10] . isation Ca enters the cell through L-type voltage-depen- 21 21 dent channels as an inward Ca current (cardiac action To maintain cellular steady state conditions the Ca potential phase 2). The spatial organisation of RyR, influx into the cell must be balanced by efflux through the 1 21 adjacent to L-type voltage-dependent channels is vital in sarcolemmal Na / Ca exchanger and at the level of the 21 21 that this inward Ca current activates adjacent RyRs to SR the amount of Ca release through RyR2 must be 21 21 release further Ca from the SR where it is stored, balanced by SR Ca /ATPase pump re-uptake. 21 Fig . 1 . The movement of Ca around the cell is shown (arrows), along with the key ion channels and pumps which orchestrate this process. Note also the 21 21 close association of SR RyR2s with sarcolemmal L-type voltage dependent channels, allowing localised Ca induced Ca release events to take place. 21 One important influence on myocardial Ca cycling is b adrenergic receptor stimulation mediated by sympa-2 .1. Calcium cycling in heart failure 1 thetic nerves and circulating catecholamines. Activation of these receptors can alter the properties of E-C coupling Any detrimental alteration to E-C coupling is a pocomponents through signal amplification cascades that tential factor in the pathogenesis of chronic heart failure. results in phosphorylation of either the ion channels and Individual components have been studied in detail and one 21 pumps themselves, or the regulatory proteins attached to consistent finding is that SR Ca load is reduced in heart 21 them (Fig. 2) . It has been appreciated for several years that failure [12, 13] . SR Ca load is a key factor in determin- 21 21 21 the amplitude of the Ca transient generated by release of ing the amount of SR Ca release each inward Ca
SR Ca into the cytosol determines the contractile force current generates. This is not just a reflection of the 21 (inotropy) of the heart. Catecholamine mediated phosavailable Ca which can be released. In addition SR 21 21 phorylation will increase (1) the inward Ca current, (2) luminal Ca is believed to be an important ligand that 21 21 SR Ca loading and (3) its release into the cytosol, regulates RyR2 gating [14, 15] . SR luminal Ca , binding thereby enhancing contractile force. Although these pathto RyR2, will increase the gain of E-C coupling by 21 ways are a normal physiological process along the theme allowing a greater release of Ca for any given trigger, 21 of the 'fight and flight response', catecholaminergic input thus amplifying myocyte contraction. As SR [Ca ] rises 21 may also modify the function of RyR2 and other E-C the proportion of available SR Ca pool released through coupling components, resulting in changes, which far from RyR2 is also increased [16, 17] . The implications of this 21 21 being helpful may actually contribute to the pathogenesis Ca -mediated amplification of SR Ca release in heart sequale include (1) Ca influx into the cell, (2) SR Ca release, (3) SR Ca uptake and (4) dissociation of Ca from myofilament proteins. Although 21 21 SR Ca uptake has an initial lusitropic effect, accelerating relaxation, it also enhances the next contraction cycle by increasing the SR Ca content available for subsequent release. 21 heart failure not only reduces the total Ca load available or in the levels of relevant gene expression. Unfortunately for release but the reduction of its direct influence on the wide range of experimental models and protocols RyR2 gating also reduces the channel's open probability, employed in such studies have resulted in conflicting 21 further impairing Ca release. Thus for every carresults which make the development of firm conclusions diomyocyte depolarisation in heart failure where SR difficult. As an illustration of this ryanodine binding 21 21 [Ca ] load is reduced, SR Ca release is curtailed studies, which provide both quantitative and qualitative further and reduced contractile force is generated.
information about the number of RyR2 channels present 21 Two states that appear to bring about reduced SR Ca within the myocardium, have shown the number of funcloading in heart failure are an up-regulation of the sartionally active channels (which can assume an open 1 21 colemmal Na / Ca exchanger [18] and a reduced activiconfiguration for ryanodine to bind with) to be unchanged 21 ty of the SR Ca /ATPase pump [19] . Both these states [23] , increased [24] and decreased [25] in a variety of 21 could impair the restoration of SR Ca stores during animal models. Left ventricular hypertrophy and cardiastole, hindering the cells ability to make available the diomyopathy models of heart failure in particular have 21 required Ca for the next wave of depolarisation. This is produced conflicting results concerning the numbers of believed to be a primary factor in the defective E-C RyR channels present and the relevant levels of RyR2 gene coupling process in heart failure [13] .
expression. Several studies suggest RyR numbers are initially preserved but gradually fall as heart failure 2 .2. Does RyR2 dysfunction contribute to deranged E-C advances [26] , where as others suggest relative differences coupling in heart failure?
between different channels are of more importance than simply considering the numbers of RyR channels in It is logical to ask if RyR2 contributes to reduced SR isolation. Milnes and MacLeod, using a LVH model 21 Ca release in heart failure, or whether this is simply a showed that the number of RyR channels relative to L type function of impaired SR loading. Biological plausibility for voltage-dependent channels was reduced causing a funcRyR2 dysfunction being a potential causative mechanism tional uncoupling of the two channels and a defective 21 in the development of heart failure is obtained from studies release of Ca from the SR as a result [27] . Gomez et al. using the administration of ryanodine, which binds to RyR [28] also identified a deficit in the normal functional and dramatically modifies channel function, inducing a coupling of these two channels, although in their experi- 21 state of reduced open probability and modified Ca ments the numbers of channels relative to each other release. The administration of ryanodine would thus be remained unchanged. They demonstrated that the ability of 21 21 expected to sufficiently compromise normal in vivo RyR2 the inward Ca transient to trigger SR Ca release was function to the extent that its administration gives an curtailed in models of both heart failure and left ventricular indication as to the pathological consequences of RyR2 hypertrophy. This functional uncoupling of the two chan-21 dysfunction and reduced SR Ca release. Ryanodine nels was reversed by b adrenergic stimulation in left 1 administration does indeed depress both systolic and ventricular hypertrophy but not in heart failure, suggesting diastolic cardiac function [20, 21] and this observation is in that progression from hypertrophy to failure was marked keeping with the hypothesis that a decline in either the by a loss of this compensatory mechanism. A more innumber or function of RyR channels would contribute to depth discussion of the conflicting studies relating to levels the pathogenesis of heart failure.
of gene expression and receptor numbers is available [29] . 21 An alternative view is that if SR Ca load was reduced in heart failure any compensatory mechanism affecting 2 .3. RyR2 function in human heart failure RyR function would increase the channel's open probabili- 21 ty in order to maximise SR Ca release. Evidence for this
The practical limitations of studying RyR2 function in is now emerging. Using cardiomyocytes isolated from a human heart failure are considerable. What data is availcanine heart failure model, Yamamota et al. [22] showed able supports the view that RyR2 function is unchanged 21 that, as expected, SR Ca uptake and release was and / or unimportant in heart failure E-C coupling. Hol- 21 reduced, resulting in a reduced intracellular Ca transient mberg and Williams [30] , using end-stage failing hearts and reduced contraction. They also demonstrated however, removed at transplantation, were able to carry out a 21 that the fraction of total SR Ca released at any given SR functional assessment of extracted RyR2 channels, recon-
[Ca ] was higher in the heart failure model compared to stituted into artificial lipid bilayers. They could find no controls. These observations imply that compensatory significant difference in the properties of such channels, modulation of RyR function exists in heart failure to compared with channels from normal sheep hearts, sup-21 overcome reduced SR Ca release by increasing the porting the view that RyR2 function is preserved even in channel's open probability.
end-stage human heart failure. Furthermore Lindner et al. 21 Many investigators have attempted to gain an insight [13] showed that the depressed systolic Ca transients into the altered dynamics of heart failure E-C coupling by observed in myocytes from failing human hearts could be 21 measuring changes in the number of ion channels present explained solely through depressed SR Ca /ATPase pump activity, with no additional RyR2 dysfunction state myocyte contraction in the non-failing heart, with SR 21 21 needed to produce the observed depressed Ca transient. Ca /ATPase pump activity being the more important In summary it would appear that in severe heart failure regulatory component. They have shown that when there is RyR2 remains functional and as demonstrated by an abrupt increase in RyR2 opening, much of the addition- 21 Yamamota et al. [22] may even have augmented functional al Ca released will be rapidly removed from the 1 21 characteristics. As alluded to in Section 1 the compensatmyocyte by the Na / Ca exchanger, thereby reducing 21 21 ory mechanisms that augment RyR2 function may actually the pool of cytosolic Ca available to replenish SR Ca have an adverse effect on myocardial function, rather than stores during diastole. As a result the subsequent reduced 21 a helpful one. SR Ca content rapidly offsets the effects of increased 21 RyR2 opening such that the amplitude of the Ca 2 .4. Catecholaminergic modulation of RyR2 in heart transient and myocyte contraction remains unchanged. failure Although controversy remains regarding the importance of RyR2 phosphorylation under normal physiological Excessive activity of the sympathetic nervous system conditions there seems little doubt that catecholamineand adrenal gland produces a hyper-adrenergic state in mediated phosphorylation of E-C components is a com- 21 heart failure to maintain cardiac output and blood pressure. pensatory response to deranged Ca cycling in heart Although b adrenergic receptors are actually down-regfailure. This is believed to underlie the cellular mechaulated in heart failure, catecholaminergic modification of nisms by which positive inotropic drugs transiently im-E-C coupling is believed, nevertheless, to exert an improve cardiac function. Long term such drugs actually portant effect on this pathophysiological state.
worsen mortality in chronic heart failure despite the shortIt is well established that phosphorylation of phosterm improvements in a variety of haemodynamic parame- 21 pholamban increases the uptake of Ca into the SR ters [38] . This discrepancy could be explained by the fact 21 through the SR Ca /ATPase pump [31] , a process that in chronic heart failure long-term activation of b 1 inhibited by phospholamban in the non-phosphorylated adrenoceptors and subsequent phosphorylation of E-C state. This compensatory mechanism is unable to restore coupling components, such as RyR2, has unwanted de- 21 SR Ca levels to normal in heart failure, but appears to leterious effects on cardiomyocyte function, cell repair and 21 provide a mechanism whereby deranged Ca cycling is at apoptosis, which increase mortality rather than improve it. least limited. Investigators have also studied RyR2 with respect to phosphorylation and asked whether it too can be modified to maximise myocyte contraction in heart failure.
2 .5. RyR2 hyperphosphorylation in heart failure There is certainly circumstantial evidence for this. Multiple phosphorylation sites have been identified on RyR2 and
In a series of experiments Marks and co-workers have the channel is known to co-assemble with a variety of shown that RyR2 becomes hyperphosphorylated in chronic enzymes that mediate this modification [32] . Hain et al. heart failure [35, 39, 40] . Observed consequences of this are [33] showed that RyR2 must be phosphorylated in order to a dissociation of the regulatory protein FKBP12.6 (which 21 be active at physiological [Mg ] and studies have reis proposed to play a role in orchestrating coupled gating ported that phosphorylation increases the open probability between adjacent channels [41] ) and a functional change in 21 21 of [35] . Such compensatory modulation of RyR2 function [40, 42] . They propose that although phosphorylation of 21 would be helpful in heart failure where SR Ca release is RyR2 occurs as a compensatory response in failing hearts, impaired.
its continuation for a prolonged period will eventually Although phosphorylation may alter the functional become counterproductive to cardiac function. characteristics of RyR2 there is evidence in the non-failing Further evidence supporting this hypothesis is provided heart that, despite this, its significance as a mechanism for by observations that oral b blockers reverse RyR2 hy- 21 21 regulating myocyte Ca cycling and SR Ca load is perphosphorylation, restore the stoichiometry of the RyR2-minimal. Li et al. [36] have reported that protein kinase A FKBP 12.6 complex and normalise RyR2 function [43, 44] . 21 mediated increases in Ca spark frequency are entirely This is particularly interesting as the cellular mechanisms attributable to phospholamban phosphorylation and enby which b blockers enhance heart failure survival, yet at 21 hanced SR Ca loading, with RyR2 phosphorylation the same time hinder contraction in normal hearts, have 21 having no effect on Ca spark frequency. Furthermore a never been adequately explained. series of investigations by Eisner [37] argue strongly that As more evidence emerges to clarify the role of RyR2 RyR2 has only a minimal role in the regulation of steadyhyperphosphorylation and its consequences in heart failure, Ca release gain [45] . This observed functional deficit is One form of ARVC, classified subtype 2, is characterin keeping with previous work that has suggested dissociaised by an association with exercise-induced arrhythmias, a tion of FKBP 12.6 from RyR2 was associated with an high penetrance and an equal male / female ratio (other increased channel open probability [46] . It thus appears forms tend to have a male predilection). It was first that FKBP 12.6 serves to modulate channel function and described in 1988 [52] and following its linkage to the prevent excessive non-physiological opening of the chanRyR2 chromosomal loci 1q42-43 [53,54] Tiso et al. 21 nel and a subsequent detrimental SR Ca leak. Several recently identified four missense mutations of RyR2 in studies have shown that FKBP 12.6 levels are significantly four independent affected families [55]. All four mutations reduced in heart failure models [47, 48] and this observawere mapped to two highly conserved regions of RyR2 tion is believed, at least in part, to explain the abnormal SR that code for cytoplasmic domains of the channel and 21 Ca leak observed in these models [47] . Such studies correspond to similar regions of the RyR1 gene where point to a decrease in FKBP 12.6 numbers or function as mutations underlying malignant hyperthermia and central an important pathophysiological development in heart core disease are found [56] (Fig. 3) . These RyR1 mutafailure in its own right. This may be in addition to the tions have been proposed to cause an increased leak of though this may help explain the association of ARVC The recent unexpected findings of cardiac hypertrophy type 2 with exercise-induced arrhythmias the mechanisms in FKBP 12.6 null mice and the protecting influence on the behind observed structural abnormalities in ARVC is less development of this phenotype by oestrogen [45] has clear. Nevertheless the identification of a specific genetic certainly raised the profile of this RyR2 associated protein cause for ARVC will assist in familial screening and and more studies clarifying its precise role and importance diagnosis and this is particularly important in a condition in cardiac disease states can be expected.
where the first presentation can be sudden death and where normal non-invasive investigations do not exclude the diagnosis.
. Cardiac arrhythmias and RyR2 dysfunction .2. Catecholaminergic polymorphic ventricular Two forms of sudden cardiac death in children have
tachycardia recently been shown to result from autosomal dominant mutations in RyR2. Both these conditions, catechola-CPVT is characterised by adrenergic induced arrhythminergic / polymorphic ventricular tachycardia (CPVT) and mias in the form of bi-directional and polymorphic venarrhythmogenic right ventricular cardiomyopathy (ARVC) tricular tachycardia [42, 58, 59] . It is one of a small group of subtype 2 share the common clinical feature of exercise rare inherited disorders including the congenital long QT and stress induced ventricular arrhythmias.
and Brugada syndromes that can cause malignant ventricular arrhythmias in the absence of structural heart disease 3 .1. Arrhythmogenic right ventricular cardiomyopathy [60] . It is a rare disorder however it has a high mortality rate (up to 50% by the age of 30 [61] ) and can present as ARVC is an acronym for a genetically heterogeneous sudden cardiac death without warning in children and group of cardiomyopathies, characterised by structural and young adults. For these reasons all physicians dealing with functional abnormalities of the right ventricle and progreschildhood syncope and collapse should be aware of its sive replacement of the right ventricle free wall with existence. fibrous and fatty tissue [49, 50] . It presents with arrhyth-CPVT was first reported as a case of exercise induced mias of right ventricular origin and if sudden death is bi-directional tachycardia in the early 1970s [62] . Numer- ous short series and case reports followed [63] yet it was tions identified in RyR2 and associated with exercise not until Leenhart et al. reported a 10 year follow-up of 21 induced arrhythmic disorders to 11 (Fig. 3) . These mutachildren with the disorder in 1995 [59] that it became tions cluster in three regions of the RyR2 gene that are established as a distinct clinical entity. Cases have been comparable to three regions in RyR1 where mutations reported throughout the world and both sexes appear to be underlying malignant hyperthermia and central core dissusceptible. Its key features include a childhood onset of ease are found. This would suggest that these are highly syncope and collapse brought on by exercise and other conserved regions of both the RyR1 and RyR2 genes, stressful scenarios, with reproducible polymorphic and / or which have an important role in regulating channel funcbi-directional ventricular tachycardia demonstrated during tion. exercise testing and catecholamine infusion. Cardiac inAn autosomal recessive form of CPVT also exists and vestigations show no evidence of structural heart disease the genetic basis of this form has been pinpointed to a and the resting 12-lead electrocardiogram is unremarkable highly conserved region of the calsequestrin 2 gene by with a normal QT interval.
Lahat and co-workers [66] . The mutation appears to 21 disrupt Ca binding to calsequestrin, and Lahat speculates Furthermore the nature of CPVT would suggest that these clinically affected members of the same family. Laitenen et mutations alter the normal physiological response of the al. [65] identified three mutations in three unrelated channel to increased catecholaminergic drive during exerfamilies. Along with the four ARVD mutations already cise. Although characterisation of these mutations is not mentioned this brings the total number of missense mutayet available it is possible to gain some insight into the likely pathophysiological mechanisms behind CPVT by 3 .6. Bi-directional ventricular tachycardia is a triggered considering the peculiar arrhythmia strongly associated arrhythmia resulting from delayed afterdepolarisations with it, namely bi-directional ventricular tachycardia.
secondary to intracellular calcium overload and spontaneous SR calcium release 3 .
Bi-directional ventricular tachycardia: a marker of abnormal RyR function?
Abnormal impulse generations that can initiate cardiac arrhythmias are generally believed to originate from either Bi-directional ventricular tachycardia is a rare and automaticity or triggered activity [70] . Triggered activity is unusual arrhythmia first described in 1922 [67] . Although so-called because unlike the spontaneous depolarisations of it is consistently associated with CPVT it is better known automaticity the impulse can only occur if it follows a for its association with digoxin toxicity [68] . It is a broad previous action potential, i.e. it is said to be triggered by complex tachycardia with a curious alternating QRS the previous impulse. Triggered impulses result from subcomplex polarity and its origins remained unclear for many threshold membrane depolarisations, termed afterdepolariyears until Cohen and co-workers [69] finally demonsations, which follow the previous action potential. They strated that it was in fact a ventricular arrhythmia originacan occur during repolarisation of the previous impulse ting close to the common undivided part of the left bundle where they are called early afterdepolarisations (EADs), or branch. They showed that its unique ECG morphology they can occur after repolarisation is complete where they resulted from conduction within the left ventricle alternatare known as delayed afterdepolarisations (DADs) (Fig. 5) . ing between the anterior and posterior fascicle of the EADs occur when the action potential duration is bundle, due to an alternating refractoriness in the other extended. Reviews of their importance and electrochemical fascicle (Fig. 4) .
generation can be found elsewhere [70] . DADs, which are believed to be the underlying cause of bi-directional cause DADs in cardiomyocytes [74, 77] . These drugs 21 ventricular tachycardia [70] and hence arrhythmia geneincrease intracellular [Ca ] , and hence conditions which ration in CPVT [64], result from a transient inward current favour DAD generation, because in an attempt to remove 21 1 evoked by spontaneous Ca release from the SR under excess cytosolic Na resulting from the drug's action on
conditions that favour accumulation of cellular Ca [70-the sarcolemmal Na / K ATPase pump, Na is removed 21 72] . If this inward current is sufficient to cause a DAD in exchange for an inward movement of Ca through the 1 21 whose amplitude exceeds the threshold potential, depolarsarcolemmal Na / Ca exchanger [77] . The realisation isation will occur. The abnormal impulse generated from that RyR2 mutations are associated with bi-directional this can cause a triggered arrhythmia if surrounding ventricular tachycardia raises the possibility that the mechpolarised cells propagate the depolarisation wave. Several anism whereby glycosides bring about this arrhythmia is factors increase the amplitude of DADs and hence the also linked to a direct action on RyR2. Work in our probability that the threshold potential will be reached.
laboratory [78] and by others [79] has shown that cardiac These include increasing the rate of the triggering action glycosides do have a direct action on RyR2, leading to an potential (corresponding to an increase in heart rate) and increased open probability of the channel. It is possible increasing intracellular calcium loading [73] . This latter that bi-directional ventricular tachycardia is a manicondition is brought about by cardiac glycoside toxicity festation of DADs, brought about by an unwanted diastolic 21 [74] and catecholaminergic influence on the heart will release of SR Ca , which is itself a manifestation of increase DAD amplitude by both these mechanisms abnormal RyR2 function secondary to unwanted cardiac [75, 76] . Hypercalcaemia alone does not cause this parglycoside action or CPVT mutations. ticular arrhythmia. Presumably without the additional A convincing case for the role of DADs in bi-directional 21 actions of digoxin or RyR2 mutations any increased Ca ventricular tachycardia is not only supported by work influx into the cell is successfully buffered and / or balcharacterising arrhythmia generation secondary to digoxin 21 21 anced by Ca efflux, such that SR Ca levels remain toxicity. There is now direct evidence from electrophysiorelatively normal preventing any spontaneous diastolic logical studies during catecholamine infusion in CPVT that 21 Ca leak. DAD generation occurs and does indeed result in the Cardiac glycosides have consistently been shown to generation of bi-directional ventricular tachycardia [80] .
Furthermore it is possible that only a brief period of others, suggests that intrinsic regulation of RyR2 has, on exercise would be needed to initiate a triggered arrhythmia its own, minimal long-term influence on the amount of 21 by the above mechanisms. Once generated the arrhythmia Ca released from the SR. Until results on the functional characterisation of CPVT for RyR2 in the process of SR Ca release? mutations emerge our knowledge of bi-directional venWe suggest that these two arguments are not necessarily tricular tachycardia and how DADs are generated allow us mutually exclusive and indeed result in an interesting to speculate that CPVT results from mutations which allow hypothesis in which CPVT mutations in RyR2 actually 21 an excessive Ca release from the SR, particularly during result in a move in the direction of reduced open probabilidiastole when the channel would normally be closed.
ty, as opposed to the 'gain in function' mutation theory One question that needs to be asked is how do these mentioned above. If mutations in RyR2 promote an 21 mutations result in a gain in function that is only revealed environment whereby Ca release is curtailed, feedback in the context of a catecholaminergic stimulus? One mechanisms would be expected to promote an increased 21 21 possible answer appears from the analogue of maladaptive uptake of Ca into the SR, through the Ca /ATPase hyperphosphorylation in chronic heart failure, which may pump, to compensate for this deficient release. This would 21 21 also such as bi-directional ventricular tachycardia to develop. of the SR with Ca , again working to overcome the Such a modification of function would also explain how, inhibitory constraints of the mutations (Fig. 6) . The under normal circumstances where there is no excessive development of transgenic animal models containing sympathetic drive, the mutations remain silent having no CPVT mutations will facilitate the measurement of SR 21 noticeable effect on channel function. Ca content in this condition and help elucidate whether 21 As with ARVC type 2 we can also gain insight into the steady-state Ca concentration is indeed elevated. functional consequences of these mutations by looking at studies of similar RyR1 mutations which underlie malignant hyperthermia and central core disease and are seen to 3 .9. RyR2 dysfunction and atrial arrhythmias cluster in three corresponding regions of the RyR1 gene as the identified CPVT mutations in RyR2 (Fig. 3) . It has To our knowledge the only other cardiac arrhythmia that been proposed that these mutations lead to a 'gain in has received attention with regards to RyR2 dysfunction is function' and increased channel opening [57] . atrial fibrillation. With respect to this common arrhythmia, studies have attempted to clarify changes in the density 21 3 .8. CPVT may be caused by RyR2 mutations that and expression levels of various Ca regulatory proteins, reduce channel opening including RyR2. Ohkusa et al. [81] found that there was a significant reduction in the maximum number of ryanodine 21 The mechanisms that govern SR Ca loading and binding sites (B ) in atrial tissue taken from mitral valve max release are key factors in determining myocardial contracdisease patients with chronic atrial fibrillation. Corretion and the development of pro-arrhythmic states outlined spondingly they also showed that the expression levels of 21 above. These include (1) the magnitude of Ca influx into RyR2 mRNA were also reduced. The authors speculate the cell through the sarcolemmal L-type voltage-dependent that these observed abnormalities may have importance in 21 21 Ca channel, (2) the uptake of Ca into the SR through the initiation and / or propagation of atrial fibrillation, 21 21 the SR Ca /ATPase pump, (3) the Ca buffering although they concede that a specific causative role cannot capacity of the SR and (4) the intrinsic gating properties of be inferred from such observations alone. Furthermore Lai RyR2. All of these are targets for phosphorylation-meet al. [82] also looked at the expression levels of several 21 diated modulation, brought about by increased sympathetic Ca handling genes in atrial tissue from chronic atrial drive. The experimental work of Eisner [37] , Li [36] and fibrillation patients. They conversely found no significant 21 21 Fig changes in the level of RyR2 gene expression and at There is now clear evidence that RyR2 modulation, present the precise role, if any, of RyR2 in the pathoeither as a primary event or more likely secondary to other genesis of atrial fibrillation remains to be established.
pathophysiological processes within the cell, is an important factor in chronic heart failure, regardless of its underlying aetiology. RyR2 dysfunction may not only 4 . Concluding comments result in impaired contraction but it may also predispose to intracellular conditions that favour arrhythmia generation. In this article we have summarised the role played by This emerging knowledge raises the possibility that theraRyR2 in cardiac E-C coupling. As its role in normal peutic manipulation of RyR2 may be a further possible myocardial physiology has become clearer it is not surpristarget for drug therapy in heart failure, in fact it is likely ing that it has been seen as a potential factor in heart that the benefits of b blockers in this condition are, in part, failure and arrhythmia generation, two pathophysiological a result of their indirect action on the phosphorylation state processes that can occur when E-C coupling is deranged. of RyR2.
regulation by endogenous effectors. Annu Rev Physiol
The arrhythmogenic potential of RyR2 is further demon- emerge not only will targeted drug strategies become tions has now emerged. Jiang et al. [83] , working on the 
